QUICNAC AB
Acetylcysteine 600mg + Acebrophylline 100mg Tablet
QUALITATIVE AND QUANTITATIVE COMPOSITION: Each tablet
contains 600 mg of Acetylcysteine + Acebrophylline 100mg.
INDICATION: In Moderate to Severe Asthma and COPD
Patients, DOSAGE AND METHOD OF ADMINISTRATION: Dosage -
One tablet/day is recommended for adults and older.
CONTRAINDICATIONS: Hypersensitivity to the active
substance or any of the excipients. Individuals under 14 years of age.
WARNING AND PRECAUTION: Bronchospasms may occur with
N-acetylcysteine use, requiring immediate discontinuation. Severe skin
reactions are rare but possible; medical advice is needed if new skin
changes occur. UNDESIRABLE EFFECTS: Nausea, dizziness,
abdominal discomfort/distension, vomiting, heart burn, constipation,
breathlessness, leukocytosis.
DRUG INTERACTIONS: Allopurinol, ciprofloxacin,
corticosteroids, diltiazem, erythromycin, furosemide, isoprenaline,
thiabendazole, verapamil, doxycycline may reduce clearance of active
ingredients and hence dose reduction may be advised. Caution is advised
in severe asthma. USE IN SPECIAL POPULATION: Not
recommended in pregnancy as well as during parturition. Safety of
Acebrophylline is not established during lactation. Hence its use is not
advised in lactating mothers. These highlights do not include all the
information needed to use QUICNAC AB effectively and safely. Please
refer to full prescribing information [available on request].
FOR FURTHER INFORMATION, CONTACT: Medical Affairs;
Alkem House; Senapati Bapat Marg, Lower Parel, Mumbai, Maharashtra: 400
013. Prepared on 4th June 2024. Source: Prescribing Information QUICNAC
AB